東正金融(02718.HK):中國正通售股事項盡調進入後期階段
格隆匯11月9日丨東正金融(02718.HK)公佈,有關公司控股股東中國正通與可能買方就潛在出售事項的討論;倘潛在出售事項落實,將導致公司的控制權發生變動及根據收購守則規則26.1提出強制性全面要約。於2021年11月9日:
(i) 可能買方及其專業顧問對公司開展盡職審查仍在進行,包括審查公司業務、公司資料及數據。根據提供予董事會的資料(包括可能買方及中國正通的最新資料),董事會獲悉,盡職審查工作已進入後期階段及並無商定完成盡職審查的最後期限;
(ii) 中國正通與可能買方就潛在出售事項的討論仍在進行;及
(iii) 可能買方尚未就潛在出售事項訂立任何協議或做出其他承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.